Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DE L'EUROPE : revenue, balance sheet and financial ratios

SELARL PHARMACIE DE L'EUROPE is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BRIVE-LA-GAILLARDE (19100), this company of category PME shows in 2024 a net income positive of 517 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DE L'EUROPE (SIREN 529361842)
Indicator 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 516 738 € 532 532 € 425 196 € 182 808 € 375 680 € 441 943 € 503 976 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELARL PHARMACIE DE L'EUROPE generates positive net income of 517 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 504 k€ -> 517 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

516 738 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 67%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

23.486%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

67.231%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

69.5%

Solvency indicators evolution
SELARL PHARMACIE DE L'EUROPE

Sector positioning

Debt ratio
23.49 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good -17 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE DE L'EUROPE (23.49) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
67.23% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +18 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE DE L'EUROPE (67.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 226.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

226.74

Liquidity indicators evolution
SELARL PHARMACIE DE L'EUROPE

Sector positioning

Liquidity ratio
226.74 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good -6 pts over 3 years

In 2024, the liquidity ratio of SELARL PHARMACIE DE L'EUROPE (226.74) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL PHARMACIE DE L'EUROPE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DE L'EUROPE is estimated at 7 214 044 € (range 5 023 746€ - 10 792 623€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
5023k€ 7214k€ 10792k€
7 214 044 € Range: 5 023 746€ - 10 792 623€
NAF 5 année 2024

Valuation method used

Net Income Multiple
516 738 € × 14.0x = 7 214 045 €
Range: 5 023 747€ - 10 792 623€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DE L'EUROPE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DE L'EUROPE

What is the revenue of SELARL PHARMACIE DE L'EUROPE ?

The revenue of SELARL PHARMACIE DE L'EUROPE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DE L'EUROPE profitable?

Yes, SELARL PHARMACIE DE L'EUROPE generated a net profit of 517 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DE L'EUROPE ?

The headquarters of SELARL PHARMACIE DE L'EUROPE is located in BRIVE-LA-GAILLARDE (19100), in the department Correze.

Where to find the tax return of SELARL PHARMACIE DE L'EUROPE ?

The tax return of SELARL PHARMACIE DE L'EUROPE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DE L'EUROPE operate?

SELARL PHARMACIE DE L'EUROPE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.